Absence oftpr-metand expression ofc-metin human gastric mucosa and carcinoma
- 5 July 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 194 (4), 428-435
- https://doi.org/10.1002/path.934
Abstract
The c-met proto-oncogene, encoding the hepatocyte growth factor receptor, can be activated by various mechanisms. These include, among others, gene amplification with concomitant overexpression and the tpr–met oncogenic rearrangement. In the case of gastric cancer, contradictory results on the presence of the tpr–met oncogenic rearrangement have been published. The current study aimed therefore to assess the prevalence of tpr–met expression in Caucasian gastric adenocarcinomas, to evaluate the importance of this oncogene in their carcinogenesis. In addition, the level of c-met expression was determined, to evaluate the role of this alternative mode of activation of the proto-oncogene. A series of Caucasian gastric adenocarcinomas (n=43) and normal gastric mucosal samples (n=14) was analysed for tpr–met and c-met expression. Expression of tpr–met mRNA in the samples was performed by two reverse transcriptase polymerase chain reaction (RT-PCR) assays, with excellent correlation. The specificity of both methods was confirmed by direct sequencing of the PCR products of the MNNG-HOS cell line, which is known to contain the rearrangement. The level of c-met expression was assessed using semi-quantitative RT-PCR assays and immunohistochemistry (IHC). None of the normal gastric mucosal or gastric adenocarcinoma samples expressed tpr–met mRNA, as determined by both RT-PCR assays. Seventy per cent of the adenocarcinomas showed overexpression of c-met, according to elevated c-met mRNA levels, compared with the expression level of normal gastric mucosa. A significant correlation was found between the level of c-met mRNA and protein expression. In conclusion, these results strongly suggest that tpr–met activation does not play a role in Caucasian gastric carcinogenesis, while overexpression of the c-met gene occurs in the majority of Caucasian gastric adenocarcinomas. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancerCritical Reviews in Oncology/Hematology, 1999
- The mutationally activated Met receptor mediates motility and metastasisProceedings of the National Academy of Sciences, 1998
- Signaling requirements for oncogenic forms of the Met tyrosine kinase receptorOncogene, 1998
- Activating mutations for the Met tyrosine kinase receptor in human cancerProceedings of the National Academy of Sciences, 1997
- Molecular mechanism of stomach carcinogenesisZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.Molecular and Cellular Biology, 1992
- Frequent amplification of the c-met gene in scirrhous type stomach cancerBiochemical and Biophysical Research Communications, 1992
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991
- The activated human met gene encodes a protein tyrosine kinaseFEBS Letters, 1986
- Mechanism of met oncogene activationCell, 1986